Xtant Medical Holdings (XTNT) Cash from Operations Growth (3y) (2013 - 2025)
Xtant Medical Holdings (XTNT) Cash from Operations Growth (3y) (2013 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 184.21 Bn | 176.92 Bn | 6.27 Bn | 4.78% |
| 2 | Stryker | 128.90 Bn | 126.02 Bn | 3.81 Bn | 9.30% |
| 3 | Medtronic | 109.00 Bn | 99.78 Bn | 6.41 Bn | 1.51% |
| 4 | Boston Scientific | 68.62 Bn | 67.16 Bn | 3.61 Bn | 22.35% |
| 5 | Edwards Lifesciences | 47.39 Bn | 43.72 Bn | 1.29 Bn | -48.14% |
| 6 | GE HealthCare Technologies | 28.44 Bn | 26.16 Bn | 1.98 Bn | -14.75% |
| 7 | Dexcom | 28.39 Bn | 27.27 Bn | 750.30 Mn | 50.11% |
| 8 | Smith & Nephew | 27.03 Bn | 26.46 Bn | - | - |
| 9 | Koninklijke Philips | 25.55 Bn | 22.43 Bn | 2.07 Bn | 0.50% |
| 10 | Xtant Medical Holdings | 57.21 Mn | 39.88 Mn | 17.75 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 61.78% |
| Jun 30, 2025 | 339.80% |
| Mar 31, 2025 | 48.47% |
| Dec 31, 2024 | 16.28% |
| Sep 30, 2024 | -22.88% |
| Jun 30, 2024 | -62.14% |
| Mar 31, 2024 | -63.90% |
| Dec 31, 2023 | -44.21% |
| Sep 30, 2023 | -277.98% |
| Jun 30, 2023 | -140.07% |
| Mar 31, 2023 | -7.86% |
| Dec 31, 2022 | -218.22% |
| Sep 30, 2022 | -16.78% |
| Jun 30, 2022 | -68.14% |
| Mar 31, 2022 | -59.39% |
| Dec 31, 2021 | -40.33% |
| Sep 30, 2021 | 6.23% |
| Jun 30, 2021 | 175.12% |
| Mar 31, 2021 | -96.07% |
| Dec 31, 2020 | 12.35% |